MedPath

Evaluation of Diet and Sleep in Vascular Health: A Pilot Study

Not Applicable
Terminated
Conditions
Sleep
Interventions
Behavioral: Average American Diet (AAD)
Behavioral: Mediterranean Diet
Registration Number
NCT04990973
Lead Sponsor
Columbia University
Brief Summary

The goal of this study is to test the impact of diet on sleep and cardiovascular disease risk factors.

Detailed Description

Poor sleep quality is highly prevalent in adults in the U.S. and worldwide. Recent work suggests that dietary intakes may influence sleep. This mechanistic study will test whether consuming a healthy, Mediterranean diet will improve sleep quality in U.S. adults with poor sleep and lead to better cardiovascular disease risk profile. Given the relationship between sleep and cardiovascular health, improving sleep quality through dietary measures could contribute to improving health in adults.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • Sleep >6 hours/night
  • Sleep complaints
Exclusion Criteria
  • Smoking
  • Allergies to foods
  • Inability to comply with study procedures
  • Gastrointestinal disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Mediterranean Diet and then AADMediterranean DietHealthy participants that are randomized to the MedDiet followed by a 4-week washout and a crossover to the AAD.
Mediterranean Diet and then AADAverage American Diet (AAD)Healthy participants that are randomized to the MedDiet followed by a 4-week washout and a crossover to the AAD.
Average American Diet (AAD) and then Mediterranean DietMediterranean DietHealthy participants that are randomized to AAD followed by a 4-week washout and a crossover to the Mediterranean Diet.
Average American Diet (AAD) and then Mediterranean DietAverage American Diet (AAD)Healthy participants that are randomized to AAD followed by a 4-week washout and a crossover to the Mediterranean Diet.
Primary Outcome Measures
NameTimeMethod
Score on the Pittsburgh Sleep Quality Index (PSQI)4 weeks

The 19 questions which compose this survey assess sleep quality, latency, duration, habitual sleep efficiency, sleep disturbances, medication use and daytime dysfunction. Scores range 0 (minimum) to 21 (maximum) with \>5 indicating poor sleep quality so a lower score is a better outcome.

Sleep Fragmentation Index4 weeks

Sleep Fragmentation is an index of restlessness during the sleep period expressed as a percentage (0 to 100%). The higher the index, the more sleep is disrupted.

Average Sleep Duration Per Night4 weeks

Sleep duration will be actigraphy-derived.

Secondary Outcome Measures
NameTimeMethod
Change in Urinary 6-sulfatoxymelatonin LevelChange from baseline to 4 weeks

Urinary 6-sulfatoxymelatonin will be measured by competitive ELISA and urine creatinine by clinical chemistry analyzer.

Change in TryptophanChange from baseline to 4 weeks

Tryptophan metabolism

Change in KynurenineChange from baseline to 4 weeks

Tryptophan metabolism

Change in SerotoninChange from baseline to 4 weeks

Neurotransmitter

Trial Locations

Locations (1)

Columbia University Irving Medical Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath